source
- Detalimogene Voraplasmid Yields 54% CR Rate in Heavily Pretreated BCG-Unresponsive NMIBC With CISTRAEs were generally reversible and low grade, and 96.8% of patients remained free from progression to T2 or greater disease at the data cutoff.onclive · 2mo ago↗ source
- Roswell Park Team Members Take Part in Global Conference Dedicated to Indigenous Peoples and CancerMembers of Roswell Park Comprehensive Cancer Center participated in the 2026 World Indigenous Cancer Conference.onclive · 2mo ago↗ source
- Poll Findings Highlight the Most Anticipated GU Cancer Abstracts at ASCO 2026GU experts identified key abstracts of interest from the upcoming ASCO Annual Meeting via OncLive’s social media.onclive